Health · Medical Research · 20 hrs ago

Norrin treatment prevents vision loss in diabetic rats

Norrin treatment prevents vision loss in diabetic rats

University of Michigan researchers found that norrin treatment prevented vision loss in diabetic rats.

Diabetic retinopathy is damage to blood vessels in the retina, the light-sensitive tissue at the back of the eye, and it can lead to blindness.

Current treatments often target VEGF, a protein linked to abnormal, leaky blood vessels, but they require repeated injections and do not fully help many patients.

In the study, diabetic rats had lower levels of norrin as their vision declined, and injections of the molecule helped protect their vision.

Norrin also reduced retinal cell death and inflammation, including when treatment began after vision loss had started.

The findings are promising but have not established that norrin works in people.

Researchers are studying how norrin affects genes involved in restoring the blood-vessel barrier, while related drugs that activate norrin-responsive receptors are being developed for clinical trials.

2 sources

Related

What people are saying

David AntonettiRoger W Kittendorf Research Professor of Ophthalmology and Visual Sciences at Kellogg Eye Center
There is an urgent need for new therapies that can help preserve vision in patients with diabetic retinopathy,
via News-Medical
Laura González-GonzálezPostdoctoral Fellow in the Antonetti lab
We are excited that norrin treatment can also reduce the loss of nerve cells involved in vision in diabetic rats,
via News-Medical